Associations Between GFAP, Aβ42/40 Ratio, and Perivascular Spaces and Cognitive Domains in Vascular Cognitive Impairment
International Journal of Molecular Sciences · 09.04.2025 · 26 (8) · 3541
DOI: 10.3390/ijms26083541 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.04.2025. Verfasst von Jia Dong James Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Glial Fibrillary Acidic Protein, Cognitive Dysfunction, Peptide Fragments. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Strategic Academic Initiative, Nanyang Technological University.
Abstract (Originalsprache)
Perivascular spaces (PVS) support metabolic clearance in the brain and are increasingly recognized as key contributors to dementia pathogenesis. Plasma-based biomarkers, such as glial fibrillary acidic protein (GFAP) and the amyloid β42/40 (Aβ42/40) ratio, show promise in dementia diagnosis but remain understudied in vascular cognitive impairment (VCI). VCI, a major global cause of cognitive decline, may be more prevalent in Southeast Asia. Despite its impact, it is underdiagnosed compared to Alzheimer’s, highlighting the need for early, reliable markers. This study aims to examine how these biomarkers relate to PVS burden and domain-specific cognitive outcomes in VCI. VCI was defined as global cognition as assessed by a Montreal Cognitive Assessment Score 2 or periventricular hyperintensities >3), and >1 lacuna. A total of 108 participants (mean age of 67.3 years, 51.9% female) were included. Multivariate ordinal regression assessed biomarker associations with PVS grade, adjusting for age and diastolic blood pressure. A Aβ42/40 ratio 54.1 pg/mL were used as biomarker thresholds to subgroup the participants, and the relationship between these thresholds and cognitive performance was analyzed. Elevated GFAP (p = 0.0438) and a reduced Aβ42/40 ratio (p < 0.01) were correlated with a higher PVS grade. In the subgroup with a low Aβ42/40 ratio, a greater PVS burden was associated with poorer executive function (p = 0.045, β = 0.612), while in those with high GFAP levels, it was linked to more pronounced impairments in learning and memory (p = 0.006, β = 0.375). A lower Aβ42/40 ratio and higher GFAP levels track greater PVS burden in VCI. PVS severity may be associated with domain-specific cognitive decline, highlighting the potential utility of these biomarkers in refining clinical assessments and monitoring disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
- Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore.
- National Healthcare Group, Singapore 308433, Singapore.
ORCID-Profile: Jia Dong James Wang, Yi Jin Leow, Ashwati Vipin, Nagaendran Kandiah
Förderung
- Strategic Academic Initiative
- Nanyang Technological University
Zitieren
APA
Wang, J. D. J., Leow, Y. J., Vipin, A., Sandhu, G. K., & Kandiah, N. (2025). Associations Between GFAP, Aβ42/40 Ratio, and Perivascular Spaces and Cognitive Domains in Vascular Cognitive Impairment. International Journal of Molecular Sciences, 26(8), 3541. https://doi.org/10.3390/ijms26083541
Vancouver
Wang JDJ, Leow YJ, Vipin A, Sandhu GK, Kandiah N. Associations Between GFAP, Aβ42/40 Ratio, and Perivascular Spaces and Cognitive Domains in Vascular Cognitive Impairment. International Journal of Molecular Sciences. 2025;26(8):3541. doi:10.3390/ijms26083541
BibTeX
@article{Wang2025,
author = {Wang, Jia Dong James and Leow, Yi Jin and Vipin, Ashwati and Sandhu, Gurveen Kaur and Kandiah, Nagaendran},
title = {Associations Between GFAP, Aβ42/40 Ratio, and Perivascular Spaces and Cognitive Domains in Vascular Cognitive Impairment},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3541},
doi = {10.3390/ijms26083541}
}
EUVIMED